Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Broncus HoldingBRNHF 43 Net Margin % is 682.21% as of Dec. 2025. GuruFocus rates BRNHF with a GF Score™ of 43/100. The stock has 7 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Broncus Holding ranks worse than 98.53% on this metric.
Net margin is calculated as Net Income divided by its Revenue. Broncus Holding's Net Income for the
six
months ended in Dec. 2025 was $-10.08 Mil. Broncus Holding's Revenue for the
six
months ended in Dec. 2025 was $-1.48 Mil. Therefore, Broncus Holding's net margin for the quarter that ended in Dec. 2025 was 682.21%.
The historical rank and industry rank for Broncus Holding's Net Margin % or its related term are showing as below:
BRNHF'
s Net Margin % Range Over the Past 10 Years
Min: -10271.94 Med: -395.55 Max: -188.2
Current: -9523.19
BRNHF's Net Margin % is ranked worse than 98.53% of 816
companies
in the Medical Devices & Instruments industry
Industry Median: 2.07
vs BRNHF: -9523.19
Broncus Holding (OTCPK:BRNHF) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Broncus Holding Net Margin % Related Terms
Broncus Holding Net Margin % Historical Data
* Premium members only.
The historical data trend for Broncus Holding's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Broncus Holding's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Broncus Holding Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Broncus Holding's Net Margin % distribution charts can be found below:
* The bar in red indicates where Broncus Holding's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Broncus Holding (BRNHF) has a Net Margin % of 682.21% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Broncus Holding and its competitors. According to the industry distribution chart, Broncus Holding ranks #804 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 98.5%.
Is Broncus Holding's Net Margin % too high?
Broncus Holding's current Net Margin % is 682.21%. The Medical Devices & Instruments industry median Net Margin % is 2.07. Broncus Holding's value of 682.21% is 32857% above this industry median. Based on the distribution chart, Broncus Holding ranks #804 out of 816 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Broncus Holding has a GF Score™ of 43/100, reflecting its overall financial health beyond just this single metric.
How does Broncus Holding's Net Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Broncus Holding ranks #804 out of 816 companies for Net Margin %. This places Broncus Holding in the lower half of its industry. The industry median Net Margin % is 2.07. Broncus Holding's value of 682.21% is 32857% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.07, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Broncus Holding's current Net Margin % of 682.21% is 32857% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Broncus Holding and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Broncus Holding's current Net Margin % is 682.21%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Broncus Holding stock overvalued right now?
Broncus Holding (BRNHF) has a current Net Margin % of 682.21%. The current Net Margin % is 682.21% and 32857% above the Medical Devices & Instruments industry median of 2.07. Broncus Holding's overall GF Score™ is 43/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Broncus Holding (BRNHF), the current Net Margin % is 682.21% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Broncus Holding Corp is focused on provision of interventional treatment of Chronic Obstructive Pulmonary Disease and lung cancer. It engages in the field of Interventional Pulmonology, providing solutions for lung diseases in China and globally. Its products portfolio includes the InterVapor Thermal Vapor Treatment System the only implantable medical device to treat COPD; BroncAblate Radiofrequency Ablation System the transbronchial interventional treatment product for lung cancer; Targeted Lung Denervation Radiofrequency Ablation System the self-developed targeted radiofrequency ablation system in China to reduce the risk of acute exacerbation of COPD. Geographically, the company operates in Chinese Mainland; European Union; and Other Regions.
43GF Score
Get the complete analysis for BRNHF
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BRNHF has been successfully added to your 
